Thanks to new research, a drug capable of reversing a common form of heart failure known as heart failure with preserved ejection fraction (HFpEF) may soon be available. The researchers show that a drug already approved for the treatment of some forms of cancer can reverse HFpEF symptoms and improve the heart’s ability to pump blood in an HFpEF animal model.